Search Results

FDA Clears Additional Sizes for TriReme's Chocolate PTA Balloon Catheter

June 19, 2012—TriReme Medical, Inc. (Pleasanton, CA) announced that it has received US Food and Drug Administration clearance for an expanded matrix of sizes for its Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for treatment of lesions in the peripheral vasculature in balloon diameters from 2 to 4 mm and in balloon lengths up to 120 mm.

RESULTS Registry Will Evaluate 2-Year Outcomes With Ra Medical's DABRA Excimer Laser System

June 19, 2019—Ra Medical Systems, Inc. announced it is conducting a study to demonstrate the effectiveness of the company's DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) excimer laser photoablation system to deliver long-lasting results and a low reintervention rate for patients with peripheral artery disease.

AccessClosure Launches Mynx Ace Vascular Closure Device

March 29, 2014—AccessClosure Inc. (Santa Clara, CA) announced the commercial launch of its Mynx Ace vascular closure device at ACC.14: the 63rd annual scientific session of the American College of Cardiology being held March 29–31, in Washington, DC.

CELLO Study Published for Spectranetics' Turbo-Booster

January 13, 2010—Spectranetics Corporation (Colorado Springs, CO) announced that Rajesh M. Dave, MD, et al have published results of the CELLO (Clirpath Excimer Laser System to Enlarge Lumen Openings) registry in the Journal of Endovascular Therapy (2009;16:665–675). CELLO evaluated the effectiveness of excimer laser ablation with the company's Turbo-Booster for patients with peripheral artery disease (PAD).

Published CELLO Study Demonstrates Effectiveness of Spectranetics’ Turbo-Booster Excimer Laser Ablation System

January 13, 2010—Spectranetics Corporation (Colorado Springs, CO) announced that Rajesh M. Dave, MD, et al have published results of the CELLO (Clirpath Excimer Laser System to Enlarge Lumen Openings) registry in the Journal of Endovascular Therapy (2009;16:665–675). CELLO evaluated the effectiveness of excimer laser ablation with the company's Turbo-Booster for patients with peripheral arterial disease (PAD).

SIR Launches VIRTEX Data Registry

September 9, 2020—The Society of Interventional Radiology (SIR) recently launched the VIRTEX data registry to provide dedicated clinical data for the interventional radiology (IR) specialty.